Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database

Zavaroni, 1989, Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance, N Engl J Med, 320, 703, 10.1056/NEJM198903163201105 Bonora, 1998, Prevalence of insulin resistance in metabolic disorders. The Bruneck Study, Diabetes, 47, 1643, 10.2337/diabetes.47.10.1643 Tobey, 1981, Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man, Metabolism, 30, 165, 10.1016/0026-0495(81)90167-0 Orchard, 1983, Plasma insulin and lipoprotein concentrations: an atherogenic association?, Am J Epidemiol, 118, 326, 10.1093/oxfordjournals.aje.a113639 McKane, 1990, The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia, Metabolism, 12, 1240, 10.1016/0026-0495(90)90177-E Karhapaa, 1994, Isolated low HDL cholesterol: an insulin resistance state, Diabetes, 43, 411, 10.2337/diabetes.43.3.411 Modan, 1987, Elevated serum uric acid—a facet of hyperinsulinaemia, Diabetologia, 30, 713, 10.1007/BF00296994 Zavaroni, 1993, Changes in insulin and lipid metabolism in males with asymptomatic hyperuricemia, J Intern Med, 234, 25, 10.1111/j.1365-2796.1993.tb00700.x Bonora, 1996, Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study, Int J Obes Relat Metab Disord, 20, 975 Vuorinen-Markkola, 1994, Hyperuricemia and insulin resistance, J Clin Endocrinol Metab, 78, 25, 10.1210/jc.78.1.25 Modan, 1985, J Clin Invest, 75, 809, 10.1172/JCI111776 Bonora, 1987, Relationship between blood pressure and plasma insulin in non-obese and non-diabetic subjects, Diabetologia, 30, 719, 10.1007/BF00296995 Ferrannini, 1987, Insulin resistance in essential hypertension, N Engl J Med, 317, 350, 10.1056/NEJM198708063170605 Pollare, 1990, Insulin resistance is a characteristic feature of primary hypertension independent of obesity, Metabolism, 39, 167, 10.1016/0026-0495(90)90071-J Bonora, 1997, Relationship of fasting insulin to cardiovascular risk factor is already present in young men. The Verona Young Men Atherosclerosis Risk Factor Study, Eur J Clin Invest, 27, 248, 10.1046/j.1365-2362.1997.1060658.x Willeit, 1997, The role of insulin in age-related sex differences of cardiovascular risk profile and morbidity, Atherosclerosis, 130, 183, 10.1016/S0021-9150(96)06038-8 Reaven, 1988, Banting lecture. Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diabetes.37.12.1595 DeFronzo, 1991, Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease, Diabetes Care, 14, 173, 10.2337/diacare.14.3.173 Ferrannini, 1991, Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome, Diabetologia, 34, 416, 10.1007/BF00403180 Haffner, 1992, Prospective analysis of the insulin resistance syndrome (Syndrome X), Diabetes, 41, 715, 10.2337/diabetes.41.6.715 Meigs, 1997, Risk variable clustering in the insulin resistance syndrome, Diabetes, 46, 1594, 10.2337/diabetes.46.10.1594 Ford, 2002, Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey, JAMA, 287, 356, 10.1001/jama.287.3.356 Bonora, 2003, Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study, Int J Obes Relat Metab Disord, 27, 1283, 10.1038/sj.ijo.0802381 DeFronzo, 1979, The glucose clamp technique. A method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin, Am J Physiol, 237, E214 Robbins, 1996, Report of the American Diabetes Association's Task Force for the standardization of insulin assay, Diabetes, 45, 242, 10.2337/diabetes.45.2.242 Snedecor, 1967 Laakso, 1993, How good a marker is insulin level for insulin resistance, Am J Epidemiol, 137, 959, 10.1093/oxfordjournals.aje.a116768 Reaven, 1984, Effect of in vivo plasma insulin levels on the relationship between perfusate free fatty acid concentration and triglyceride secretion by perfused rat livers, Horm Metab Res, 16, 230, 10.1055/s-2007-1014753 Foufelle, 2002, New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription sterol regulatory element binding protein-1c, Biochem J, 366, 377, 10.1042/bj20020430 Lewis, 1993, Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL ApoB production in normal weight and obese individuals, Diabetes, 42, 833, 10.2337/diabetes.42.6.833 Lewis, 1996, Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state, Diabetes Care, 19, 390, 10.2337/diacare.19.4.390 Maheux, 1997, Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase, Diabetologia, 40, 850, 10.1007/s001250050759 Riemens, 2001, Plasma cholesteryl ester transfer and hepatic lipase activity are related to high-density lipoprotein cholesterol in association with insulin resistance in type 2 diabetic and non-diabetic subjects, Scand J Clin Lab Invest, 61, 1, 10.1080/00365510151067866 Frenais, 2001, In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus, J Clin Endocrinol Metab, 86, 1962, 10.1210/jc.86.5.1962 Pont, 2002, High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients. An in vivo stable isotope study, Int J Obes Relat Metab Disord, 26, 1151, 10.1038/sj.ijo.0802070 Knudsen, 1995, Changes of lipolytic enzymes cluster with insulin resistance syndrome, Diabetologia, 38, 48, 10.1007/BF00400640 Taskinen, 1995, Insulin resistance and lipoprotein metabolism, Curr Opin Lipidol, 6, 153, 10.1097/00041433-199506000-00007 Lewis, 2005, New insights into the regulation of HDL metabolism and reverse cholesterol transport, Circ Res, 96, 1221, 10.1161/01.RES.0000170946.56981.5c Facchini, 1991, Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance and plasma uric acid concentration, JAMA, 266, 3008, 10.1001/jama.266.21.3008 Quinones Galvan, 1995, Effect of insulin on uric acid excretion in humans, Am J Physiol, 268, E1 Leyva, 1998, The glycolytic pathway to coronary heart disease: a hypothesis, Metabolism, 47, 657, 10.1016/S0026-0495(98)90026-9 Quinones-Galvan, 1997, Renal effects of insulin in man, J Nephrol, 10, 188 Sowers, 1990, At the cutting edge. Insulin resistance and hypertension, Mol Cell Endocrinol, 74, C87, 10.1016/0303-7207(90)90110-T Steinberg, 1994, Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase oxide release, J Clin Invest, 94, 1172, 10.1172/JCI117433 Reaven, 1996, Hypertension and associated metabolic abnormalities. The role of insulin resistance and the sympathoadrenal system, N Engl J Med, 334, 374, 10.1056/NEJM199602083340607 Christensen, 1983, Acute effects of insulin on cardiovascular function and noradrenaline uptake and release, Diabetologia, 25, 377, 10.1007/BF00282513 Sowers, 1998, Insulin, cation metabolism and insulin resistance, J Basic Clin Physiol Pharmacol, 9, 223, 10.1515/JBCPP.1998.9.2-4.223 Baron, 2002, Insulin resistance and vascular function, J Diabetes Complications, 16, 92, 10.1016/S1056-8727(01)00209-4 Ferrannini, 2002, Insulin: in search of a syndrome, Diabet Med, 19, 724, 10.1046/j.1464-5491.2002.00794.x Saltiel, 2001, Insulin signalling and the regulation of glucose and lipid metabolism, Nature, 414, 799, 10.1038/414799a Cusi, 2000, Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signalling in human muscle, J Clin Invest, 105, 311, 10.1172/JCI7535 Montagnani, 2002, Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells, J Biol Chem, 277, 1794, 10.1074/jbc.M103728200 Nagi, 1993, Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups, Diabetes Care, 16, 621, 10.2337/diacare.16.4.621 Raji, 2003, Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients, Diabetes Care, 26, 172, 10.2337/diacare.26.1.172 O'Dea, 1984, Marked improvement in carbohydrate and lipid metabolism in diabetic Australian Aborigines after temporary reversion to traditional lifestyle, Diabetes, 33, 596, 10.2337/diabetes.33.6.596 Lesniak, 2001, Exercise and hypertension, Curr Opin Cardiol, 16, 356, 10.1097/00001573-200111000-00007 Hess, 2002, Nutritional aspects of stone disease, Endocrinol Metab Clin North Am, 31, 1017, 10.1016/S0889-8529(02)00029-4 Carson, 2003, Nutrition therapy for dyslipidemia, Curr Diab Rep, 3, 397, 10.1007/s11892-003-0084-z Davidson, 1997, An overview of metformin in the treatment of type 2 diabetes mellitus, Am J Med, 102, 99, 10.1016/S0002-9343(96)00353-1 Parulkar, 2001, Nonhypoglycemic effects of thiazolidinediones, Ann Intern Med, 134, 61, 10.7326/0003-4819-134-1-200101020-00014